A Case of Colchicine Toxicity Presenting With Euglycemic Diabetic Ketoacidosis

Colchicine has a narrow therapeutic window and a high risk of toxicity when co-administered with CYP3A4 inhibitors and P-glycoprotein inhibitors. Colchicine toxicity is associated with various metabolic disturbances and can cause multiorgan failure and death. However, to our knowledge, there are no...

Descripción completa

Detalles Bibliográficos
Autores principales: Delshad, Sean D, Kleiber, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292171/
https://www.ncbi.nlm.nih.gov/pubmed/37378167
http://dx.doi.org/10.7759/cureus.39063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292171/
https://www.ncbi.nlm.nih.gov/pubmed/37378167
http://dx.doi.org/10.7759/cureus.39063

Ejemplares similares